Homburger advised the selling shareholders of Samaplast, a privately held Swiss company, on the sale of 100% of the company to a group of investors led by Philipp Looser. The company Samaplast is a specialist in
Tags :Daniel Häusermann
The Kellenberger family has significantly reduced its ownership in Calida Holding through two key transactions: a public buy-back offer and a direct share repurchase. Homburger served as legal advisor to the Kellenberger family, guiding them
Homburger is acting as the legal advisor to Liberty Global and Sunrise Communications AG in relation to the spin-off and dual listing of Sunrise on the SIX Swiss Exchange and NASDAQ. The transaction, announced on
Homburger advised Meyer Burger Technology on the completion of a reverse split (on July 1, 2024) of its shares in the ratio 750:1, which had been approved by its annual general meeting of shareholders held on June 25, 2024. The
Homburger advised Santhera Pharmaceuticals on its entrance into a royalty monetization financing totaling up to USD 38 m with R-Bridge, an affiliate of CBC Group, amongst Asia’s largest healthcare-focused investment firms. Santhera is monetizing 75% of
Homburger advised ADC Therapeutics, a commercial-stage biotechnology company producing antibody drug conjugates (ADCs) for cancer patients, on its 13.4 m of common shares, and, to certain investors who so choose in lieu of common shares, pre-funded
Wöhrle Group, headquartered in Wildberg, Germany, has announced that it had acquired the Swiss Oskar Rüegg Holding and its subsidiaries (Switzerland / Bulgaria / Mexico). Both companies specialize in the manufacture of sophisticated stamped parts
Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland, the platform of a leading European energy supplier and contracting specialist GETEC Group. They are the new owner and operator of the properties and infrastructure
Santhera Pharmaceuticals Holding has completed a 10:1 reverse split of its shares, which had been approved by the shareholders on June 27, 2023, with the listing and first day of trading of the post-split shares on the SIX
Homburger has provided legal counsel to Santhera Pharmaceuticals Holding (SIX: SANN “Santhera”) on its completion of a 10:1 reverse split of its shares. The reverse split, which was approved by shareholders on June 27, 2023, resulted in the
